Evaluation the serum levels of T3, T4, TSH, Thyroglobulin and Galactin-3 in patients with benign and malignant thyroid tumors. Journal of Pharmaceutical Negative Results, [S. l.], v. 13, n. 3, p. 559–571, 2022. DOI: 10.47750/pnr.2022.13.03.085. Disponível em: https://pnrjournal.com/index.php/home/article/view/667.. Acesso em: 24 jun. 2024.